Trupanion, Inc. TRUP
Institutional shares held
36.3 Million
645K
calls
292K
puts
Total value of holdings
$1.37B
$24.3M
calls
$11M
puts
Market Cap
$1.54B
40,746,200
Shares Out.
Institutional ownership
89.11%
# of Institutions
248
We take great care to ensure that the data presented and summarized in this overview for TRUPANION, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TRUP
View all-
Black Rock Inc. New York, NY5.45MShares$206 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA4.11MShares$155 Million0.03% of portfolio
-
Aflac Inc3.64MShares$137 Million99.9% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.55MShares$134 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.3MShares$49.1 Million0.3% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.3MShares$48.9 Million0.08% of portfolio
-
State Street Corp Boston, MA1.26MShares$47.7 Million0.0% of portfolio
-
Marshall Wace, LLP London, X01.21MShares$45.7 Million0.06% of portfolio
-
Bank Of America Corp Charlotte, NC990KShares$37.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA866KShares$32.7 Million0.0% of portfolio
Latest Institutional Activity in TRUP
Top Purchases
Top Sells
About TRUP
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
Insider Transactions at TRUP
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 09
2026
|
Murray B Low Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,213
+13.06%
|
$185,704
$8.57 P/Share
|
|
Dec 29
2025
|
John R Gallagher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
430
-1.31%
|
$15,910
$37.55 P/Share
|
|
Dec 19
2025
|
Margaret Tooth CEO |
SELL
Open market or private sale
|
Direct |
9,605
-3.03%
|
$355,385
$37.9 P/Share
|
|
Dec 19
2025
|
Margaret Tooth CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+4.76%
|
$64,000
$8.93 P/Share
|
|
Nov 28
2025
|
John R Gallagher Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,383
-16.32%
|
$217,022
$34.82 P/Share
|
|
Nov 26
2025
|
Fawwad Qureshi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,202
-100.0%
|
$217,070
$35.45 P/Share
|
|
Nov 25
2025
|
Margaret Tooth CEO |
SELL
Open market or private sale
|
Direct |
9,803
-3.06%
|
$343,105
$35.31 P/Share
|
|
Nov 25
2025
|
Margaret Tooth CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,516
+2.53%
|
$100,128
$8.93 P/Share
|
|
Nov 25
2025
|
Margaret Tooth CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,776
-0.58%
|
$62,160
$35.36 P/Share
|
|
Nov 25
2025
|
Simon Wheeler EVP, Trupanion International |
SELL
Payment of exercise price or tax liability
|
Direct |
608
-1.41%
|
$21,280
$35.36 P/Share
|
|
Nov 25
2025
|
Simon Wheeler EVP, Trupanion International |
BUY
Exercise of conversion of derivative security
|
Direct |
1,296
+2.89%
|
-
|
|
Nov 25
2025
|
Fawwad Qureshi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,475
-19.21%
|
$51,625
$35.36 P/Share
|
|
Nov 25
2025
|
Fawwad Qureshi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+32.82%
|
-
|
|
Nov 25
2025
|
Emily Dreyer Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-0.9%
|
$25,095
$35.36 P/Share
|
|
Nov 25
2025
|
Emily Dreyer Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,825
+2.22%
|
-
|
|
Nov 25
2025
|
Darryl Rawlings Director |
BUY
Exercise of conversion of derivative security
|
Direct |
946
+2.65%
|
-
|
|
Nov 25
2025
|
Steve Weinrauch EVP, North Am & Vet Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.11%
|
$7,840
$35.36 P/Share
|
|
Nov 25
2025
|
Steve Weinrauch EVP, North Am & Vet Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
925
+0.45%
|
-
|
|
Nov 25
2025
|
John R Gallagher Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
493
-0.31%
|
$17,255
$35.36 P/Share
|
|
Nov 25
2025
|
John R Gallagher Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,260
+0.79%
|
-
|
Last 12 Months Summary
Buy / Acquisition
369K
Shares
From
14
Insiders
| Exercise of conversion of derivative security | 369K shares |
|---|
Sell / Disposition
258K
Shares
From
17
Insiders
| Payment of exercise price or tax liability | 95.8K shares |
|---|---|
| Open market or private sale | 162K shares |